Stay updated on HKI-272 for HER2+ Breast Cancer and Brain Metastases Clinical Trial

Sign up to get notified when there's something new on the HKI-272 for HER2+ Breast Cancer and Brain Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HKI-272 for HER2+ Breast Cancer and Brain Metastases Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the Back to Top link was removed.
    Difference
    0.6%
    Check dated 2025-09-14T23:28:44.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.6%
    Check dated 2025-09-07T20:13:17.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while several location-related terms have been removed.
    Difference
    41%
    Check dated 2025-08-31T12:33:12.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-17T04:53:37.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.3%
    Check dated 2025-08-10T00:44:40.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    4%
    Check dated 2025-08-01T19:02:33.000Z thumbnail image

Stay in the know with updates to HKI-272 for HER2+ Breast Cancer and Brain Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HKI-272 for HER2+ Breast Cancer and Brain Metastases Clinical Trial page.